RFC
Russell Frank Company Portfolio holdings
AUM
$56.9B
This Quarter Return
+6.29%
1 Year Return
+2.13%
3 Year Return
+42.97%
5 Year Return
–
10 Year Return
–
AUM
$57.2B
AUM Growth
+$57.2B
(+1.6%)
Cap. Flow
-$1.49B
Cap. Flow
% of AUM
-2.6%
Top 10 Holdings %
Top 10 Hldgs %
10.19%
Holding
3,138
New
294
Increased
1,176
Reduced
1,317
Closed
170
Top Buys
| 1 |
UBS Group
UBS
|
$161M |
| 2 |
TSMC
TSM
|
$98.9M |
| 3 |
Gilead Sciences
GILD
|
$81.5M |
| 4 |
APC
Anadarko Petroleum
APC
|
$55.9M |
| 5 |
Omnicom Group
OMC
|
$55.2M |
Top Sells
| 1 |
OUBS
USB AG (NEW)
OUBS
|
$130M |
| 2 |
Oracle
ORCL
|
$118M |
| 3 |
ConocoPhillips
COP
|
$91.9M |
| 4 |
Intel
INTC
|
$84.4M |
| 5 |
Medtronic
MDT
|
$77.8M |
Sector Composition
| 1 | Financials | 19.2% |
| 2 | Technology | 13.36% |
| 3 | Healthcare | 11.94% |
| 4 | Industrials | 11.12% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Teva Pharmaceuticals
TEVA
$21.5B
| $261M | 0.46% |
4,583,284
-103,958
| -2% | -$5.92M |
|
27
Simon Property Group
SPG
$58.7B
| $261M | 0.46% |
1,402,816
-79,138
| -5% | -$14.7M |
|
28
RTX Corp
RTX
$212B
| $260M | 0.45% |
2,238,158
+241,220
| +12% | +$28M |
|
29
American International
AIG
$45.1B
| $260M | 0.45% |
4,594,220
+78,422
| +2% | +$4.43M |
|
30
Procter & Gamble
PG
$370B
| $259M | 0.45% |
2,806,943
-163,769
| -6% | -$15.1M |
|
31
Aptiv
APTV
$17.3B
| $254M | 0.44% |
3,466,929
+55,935
| +2% | +$4.1M |
|
32
Schlumberger
SLB
$52.2B
| $250M | 0.44% |
2,926,053
-763,578
| -21% | -$65.2M |
|
33
Colgate-Palmolive
CL
$67.7B
| $246M | 0.43% |
3,512,358
-202,158
| -5% | -$14.2M |
|
34
Occidental Petroleum
OXY
$45.6B
| $242M | 0.42% |
2,973,174
+298,672
| +11% | +$15.2M |
|
35
Aon
AON
$80.6B
| $238M | 0.42% |
2,473,594
+138,141
| +6% | +$13.3M |
|
36
Mastercard
MA
$536B
| $235M | 0.41% |
2,705,462
-8,534
| -0.3% | -$742K |
|
37
Lowe's Companies
LOW
$146B
| $233M | 0.41% |
3,401,365
-310,846
| -8% | -$21.3M |
|
38
Royal Bank of Canada
RY
$205B
| $233M | 0.41% |
3,358,844
+69,737
| +2% | +$4.83M |
|
39
PNC Financial Services
PNC
$80.7B
| $230M | 0.4% |
2,555,136
-497,223
| -16% | -$44.8M |
|
40
Comcast
CMCSA
$125B
| $230M | 0.4% |
3,899,577
+215,445
| +6% | +$12.7M |
|
|
41
Gilead Sciences
GILD
$140B
| $229M | 0.4% |
2,401,183
+855,161
| +55% | +$81.5M |
|
|
MON
42
DELISTED
Monsanto Co
MON
| $228M | 0.4% |
1,881,007
+125,985
| +7% | +$15.3M |
|
43
Goldman Sachs
GS
$221B
| $227M | 0.4% |
1,161,180
-13,429
| -1% | -$2.63M |
|
44
Berkshire Hathaway Class B
BRK.B
$1.08T
| $221M | 0.39% |
1,455,526
-133,061
| -8% | -$20.2M |
|
45
Merck
MRK
$210B
| $220M | 0.39% |
3,824,400
+65,491
| +2% | +$3.78M |
|
46
Chevron
CVX
$318B
| $220M | 0.38% |
1,944,260
-222,051
| -10% | -$25.1M |
|
47
UnitedHealth
UNH
$279B
| $215M | 0.38% |
2,216,002
-106,599
| -5% | -$10.4M |
|
48
Philip Morris
PM
$254B
| $214M | 0.37% |
2,591,269
-560,601
| -18% | -$46.3M |
|
|
EMC
49
DELISTED
EMC CORPORATION
EMC
| $213M | 0.37% |
7,064,199
+687,295
| +11% | +$20.7M |
|
50
Thermo Fisher Scientific
TMO
$183B
| $210M | 0.37% |
1,660,267
-84,486
| -5% | -$10.7M |
|